Quantcast
Channel: tradingpattern.ch » Novartis
Browsing latest articles
Browse All 126 View Live

New data at ENS show Novartis drug Gilenya benefited patients by improving...

View Article



Switching to Novartis drug Gilenya from standard interferon shown to improve...

View Article

Novartis/Questcor erwirbt Rechte an Synacthen fuer 60 Mio USD Weitere Zahlungen

View Article

Novartis konzentriert ihre Schweizer Geschäftseinheiten in Rotkreuz

View Article

Novartis drug Jakavi(R) improved overall survival of myelofibrosis patients...

View Article


III Studienergebnisse zu Jakavi

View Article

FDA grants Breakthrough Therapy designation to Novartis serelaxin (RLX030)...

View Article

Novartis – Sandoz launches Phase III clinical trial for biosimilar etanercept

View Article


Novartis reports new Phase III data showing omalizumab significantly improves...

View Article


Novartis drug Lucentis approved in EU as first effective anti-VEGF treatment...

View Article

Novartis-Mittel Lucentis erhaelt neue Indikation in der EU

View Article

Novartis and Biological E agree to deliver affordable vaccines for typhoid...

View Article

Novartis erhoeht nach starkem Quartal die Jahresprognose

View Article


Novartis ist die Nummer eins

View Article

AKTIEN SCHWEIZ/Verlauf: Knapp gehalten dank Novartis UBS floppen

View Article


Novartis-Tochter Alcon soll in China Aerzte bestochen haben

View Article

Novartis hat womoeglich japanisches Recht verletzt – Experten

View Article


Novartis erhoeht trotz Gewinnrueckgang Prognose

View Article
Browsing latest articles
Browse All 126 View Live




Latest Images